Pre-earnings options volume in Ocular Therapeutix is 1.9x normal with calls leading puts 5:2. Implied volatility suggests the market is anticipating a move near 8.8%, or 94c, after results are released. Median move over the past eight quarters is 4.1%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on OCUL:
- Ocular Therapeutix price target raised to $15 from $10 at Piper Sandler
- Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
- Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Chairman and Chief Strategy Officer
- Ocular Therapeutix Raises $325M in Strategic Equity Financing
- Ocular Therapeutix reports inducement grants under Nasdaq listing rule
